Goldenwell Biotech, Inc. (GWLL)
Oxford Ledge is still expanding full research coverage of GWLL. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Goldenwell Biotech licenses biotech technology to develop freeze-dried peptide and tablet health products, with production planning complete but operations not yet active.
SEC filings
- 10-Q Quarterly financial report (unaudited) 2026-07-01
- 10-K Annual financial report with audited statements 2026-07-01
- 10-Q/A Amended quarterly report 2026-06-29
- 10-Q/A Amended quarterly report 2026-06-26
- 10-Q/A Amended quarterly report 2026-06-26
Source: SEC EDGAR.
- Open GWLL in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.